Watch our monthly newscast to see what we’re up to in October. Highlights include the upcoming PBPK modeling workshops in Asia, plus presentations at ACoP8.
Understanding dermal drug disposition using TCAT™ – a novel PBPK model…
Significant update of liver safety program includes performance and capability enhancements…
MembranePlus™ is the industry’s leading mechanistic in vitro permeability & hepatocyte modeling software – stimulate your kinetic understanding and better inform GastroPlus™ PBPK models.
Learn why hundreds of organizations, spanning all aspects of drug development from early discovery chemistry through clinical trials and on to generics, depend on us for the most comprehensive offering of powerful QSAR/PBPK modeling software and pharmacometric consulting expertise available to the pharmaceutical industry today.
Learn how you can use common in vitro or in silico predicted ADMET properties in our top-ranked physiologically based toxicokinetic (PBTK) simulations to address the 3R’s (replace, reduce, and refine) of animal testing and accurate extrapolation to humans.
Check out how our in silico modeling and simulation solutions can be used to evaluate toxicity (e.g., skin sensitization), predict toxicokinetics (local and systemic exposure of toxicants), and optimize dose and formulation strategies for products applied topically or ingested orally.
See the exciting ways we have repurposed our advanced machine learning technology, originally developed and proven best-in-class for molecule property prediction in pharmaceutical chemistry, to enable rapid development of custom applications for a wide variety of research activities.
Our commitment to user and client satisfaction is the foundation for our success and the source of long-term value for our shareholders and employees.
Stay up-to-date with our upcoming conference attendance & presentations, application webinars, and training workshop courses.
Find out how your peers are applying our technology by reviewing journal articles describing various user case studies.
Read insightful articles, our unique views on industry trends, and a whole lot more on the evolution of model-driven drug development.
There are numerous resources published & presented each month, and we want to make sure you don't miss these featured scientific talks, journal articles, and more!